ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
JH888
|
307 |
96K |
10 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
307
|
96K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
JH888
|
920 |
281K |
3 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
920
|
281K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
JH888
|
11K |
4.1M |
5 |
06/08/24 |
06/08/24 |
General
|
11K
|
4.1M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JH888
|
22K |
7.9M |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
22K
|
7.9M
|
5
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Removal from Official List
|
|
JH888
|
182 |
81K |
7 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
182
|
81K
|
7
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Removal from Official List
|
|
JH888
|
182 |
81K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
182
|
81K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JH888
|
22K |
7.9M |
1 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
22K
|
7.9M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
JH888
|
38 |
8.3K |
2 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.3K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
JH888
|
146 |
46K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
46K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JH888
|
22K |
7.9M |
0 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
22K
|
7.9M
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
JH888
|
11K |
4.1M |
13 |
10/07/24 |
10/07/24 |
General
|
11K
|
4.1M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
JH888
|
391 |
85K |
10 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
85K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
JH888
|
391 |
85K |
9 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
85K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
JH888
|
391 |
85K |
4 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
85K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
JH888
|
391 |
85K |
5 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
85K
|
5
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Company Update
|
|
JH888
|
197 |
76K |
9 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
197
|
76K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
JH888
|
2.4K |
801K |
1 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
2.4K
|
801K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
JH888
|
2.4K |
801K |
3 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
2.4K
|
801K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Company Update
|
|
JH888
|
197 |
76K |
2 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
197
|
76K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
JH888
|
920 |
281K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
920
|
281K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
JH888
|
80 |
26K |
19 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
26K
|
19
|
|
ASX - By Stock
|
88E |
Re:
Course of sales
|
|
JH888
|
10 |
5.5K |
2 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
10
|
5.5K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JH888
|
22K |
7.9M |
0 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
22K
|
7.9M
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JH888
|
22K |
7.9M |
2 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
22K
|
7.9M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
JH888
|
2.2K |
782K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.2K
|
782K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JH888
|
22K |
7.9M |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
22K
|
7.9M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
JH888
|
11K |
4.1M |
2 |
17/06/24 |
17/06/24 |
General
|
11K
|
4.1M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
JH888
|
854 |
315K |
15 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
854
|
315K
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JH888
|
22K |
7.9M |
9 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
22K
|
7.9M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
JH888
|
110 |
38K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
38K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
JH888
|
2.2K |
782K |
1 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
2.2K
|
782K
|
1
|
|
ASX - By Stock
|
88E |
Re:
Ann: Project Leonis Maiden Prospective Resource Estimate Complete
|
|
JH888
|
35 |
13K |
5 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
13K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
JH888
|
126 |
32K |
1 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
126
|
32K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
JH888
|
126 |
32K |
1 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
126
|
32K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
No news is good news
|
|
JH888
|
44 |
18K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
44
|
18K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
JH888
|
1.0K |
310K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
310K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
JH888
|
2.2K |
782K |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
2.2K
|
782K
|
6
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Upper SFS Zone Flows Light Oil
|
|
JH888
|
462 |
180K |
4 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
462
|
180K
|
4
|
|
ASX - By Stock
|
CGB |
Re:
No news is good news
|
|
JH888
|
44 |
18K |
3 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
44
|
18K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
JH888
|
234 |
68K |
3 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
234
|
68K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
No news is good news
|
|
JH888
|
44 |
18K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
44
|
18K
|
2
|
|
ASX - By Stock
|
88E |
Re:
Ann: Application for quotation of securities - 88E
|
|
JH888
|
8 |
3.7K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
8
|
3.7K
|
1
|
|
ASX - By Stock
|
88E |
Re:
Ann: Application for quotation of securities - 88E
|
|
JH888
|
8 |
3.7K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
8
|
3.7K
|
1
|
|
ASX - By Stock
|
88E |
Re:
Ann: Trading Halt
|
|
JH888
|
35 |
14K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
35
|
14K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Race Buyout vs. Licensing
|
|
JH888
|
4 |
1.7K |
13 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
4
|
1.7K
|
13
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Flow Test - Second Light Oil Discovery
|
|
JH888
|
150 |
64K |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
150
|
64K
|
7
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Removal from Official List
|
|
JH888
|
182 |
81K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
182
|
81K
|
2
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Upper SFS Zone Flows Light Oil
|
|
JH888
|
462 |
180K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
462
|
180K
|
2
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Upper SFS Zone Flows Light Oil
|
|
JH888
|
462 |
180K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
462
|
180K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Annoying adverts
|
|
JH888
|
25 |
6.4K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
25
|
6.4K
|
3
|
|